Promise Biotechnology

Promise Biotechnology is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative therapies for autoimmune and inflammatory diseases. The company leverages its expertise in immunology to develop a pipeline of small molecules and biologics targeting key pathways such as IL-17, IL-23, and JAK signaling. Its lead programs are currently undergoing clinical evaluation for dermatological and gastrointestinal conditions. Promise Biotechnology aims to provide more effective and safer treatment options for patients suffering from chronic inflammatory disorders through precision medicine approaches.